N-(hexanoyloxy)-3-(pyridin-4-yl)acrylamide

ID: ALA5203124

PubChem CID: 168292753

Max Phase: Preclinical

Molecular Formula: C16H20N2O3

Molecular Weight: 288.35

Names and Identifiers

Canonical SMILES:  CCCCCC(=O)ONC(=O)/C=C/C=C/c1ccncc1

Standard InChI:  InChI=1S/C16H20N2O3/c1-2-3-4-9-16(20)21-18-15(19)8-6-5-7-14-10-12-17-13-11-14/h5-8,10-13H,2-4,9H2,1H3,(H,18,19)/b7-5+,8-6+

Standard InChI Key:  ANYQCULAYZJYDS-KQQUZDAGSA-N

Molfile:  

 
     RDKit          2D

 21 21  0  0  0  0  0  0  0  0999 V2000
    1.7864   -0.8259    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7864   -0.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5008    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2153   -0.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9298    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6443   -0.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3589    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0718    0.4115    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3573   -0.0009    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.2366    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0716   -0.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7861    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5005   -0.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2151    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9296   -0.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6472    0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3589   -0.0030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3589   -0.8239    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6426   -1.2366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9296   -0.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  8  2  1  0
  9  8  1  0
 10  9  1  0
 10 11  2  0
 12 10  1  0
 13 12  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 16  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA5203124

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 288.35

Molecular Weight (Monoisotopic): 288.1474

AlogP: 2.81

#Rotatable Bonds: 7

Polar Surface Area: 68.29

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.90

CX Basic pKa: 5.32

CX LogP: 2.81

CX LogD: 2.81

Aromatic Rings: 1

Heavy Atoms: 21

QED Weighted: 0.36

Np Likeness Score: 0.10

References

1. Mavrikaki V, Pagonis A, Poncin I, Mallick I, Canaan S, Magrioti V, Cavalier JF..  (2022)  Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.,  64  [PMID:35307568] [10.1016/j.bmcl.2022.128692]

Source

Source(1):

• Scientific Literature